Attached files
| file | filename |
|---|---|
| EX-21.1 - EXHIBIT 21.1 - BIOVIE INC. | bivi-s1ex21z1.htm |
| EX-23.3 - EXHIBIT 23.3 - BIOVIE INC. | bivi-s1ex23z3.htm |
| EX-5.1 - EXHIBIT 5.1 - BIOVIE INC. | bivi-s1ex5z1.htm |
| S-1 - FORM S-1 - BIOVIE INC. | bivi-s1.htm |
Weinberg & Baer LLC
115 Sudbrook Lane, Baltimore, MD 21208
Phone (410) 702-5660
Mr. Jonathan Adams, Chief Executive Officer
BioVie Inc. (F/K/A NanoAntibiotics, Inc.)
100 Cummings Center, Suite 247-C
Beverly, Massachusetts 01915
Dear Mr. Adams:
CONSENT OF INDEPENDENT AUDITOR
We have issued our report dated September 27, 2016, with respect to the financial statements of BioVie Inc. (F/K/A NanoAntibiotics, Inc.) contained in the Registration Statement and Prospectus of BioVie Inc. on Form S-1. We hereby consent to the use of the aforementioned report in the Registration Statement and Prospectus, and to the use of our name as it appears under the heading “Experts.”
Respectfully submitted,
Weinberg & Baer LLC
Baltimore, Maryland
January 19, 2017